Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory response

enthalten in: Molecular therapy | 2015

von Ildefonso, C. | Jaime, H. | Biswal, M. | +4

Oral Delivery of Bioencapsulated Proteins Across Blood–Brain and Blood–Retinal Barriers

enthalten in: Molecular therapy | 2014

von Kohli, N. | Westerveld, D. | Ayache, A. | +7

ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy

enthalten in: Molecular therapy | 2012

von Verma, A. | Shan, Z. | Lei, B. | +8

Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule

enthalten in: Molecular therapy | 2011

von Lukason, M. | DuFresne, E. | Rubin, H. | +11

Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina

enthalten in: Molecular therapy | 2011

von Petrs-Silva, H. | Dinculescu, A. | Li, Q. | +14

High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors

enthalten in: Molecular therapy | 2009

von Petrs-Silva, H. | Dinculescu, A. | Li, Q. | +8

Downregulation of p22phox in Retinal Pigment Epithelial Cells Inhibits Choroidal Neovascularization in Mice

enthalten in: Molecular therapy | 2008

von Li, Q. | Dinculescu, A. | Shan, Z. | +5

AAV-2 Based Gene Therapy Using Novel Anti-VEGF Molecules for Inhibition of Angiogenesis in the Eye

enthalten in: Molecular therapy | 2006

von Scaria, A. | Pechan, P. | Rubin, H. | +8

Baculoviral IAP Repeat-Containing-4 Protects Optic Nerve Axons in a Rat Glaucoma Model

enthalten in: Molecular therapy | 2002

von Mckinnon, S. | Lehman, D. | Tahzib, N. | +6